Neurocrine Biosciences
NBIX
#1635
Rank
NZ$16.87 B
Marketcap
$170.56
Share price
1.28%
Change (1 day)
-24.03%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company